| 14th May 2025 7:00 am |
RNS-R |
Pediatric Amendment to Clinical Protocol |
| 13th May 2025 7:00 am |
RNS |
AGM Correction |
| 8th May 2025 7:00 am |
RNS |
Placing to Raise £451,250 and Director’s Dealing |
| 2nd May 2025 4:24 pm |
RNS |
Notice of AGM |
| 2nd May 2025 7:00 am |
RNS |
Second Patient Treated with HG-CT-1 CAR-T Therapy |
| 28th Apr 2025 7:00 am |
RNS |
Final Results |
| 3rd Apr 2025 7:00 am |
RNS-R |
FDA Annual Report |
| 31st Mar 2025 7:00 am |
RNS |
Total Voting Rights |
| 24th Mar 2025 7:00 am |
RNS |
First Patient Safety |
| 17th Mar 2025 7:00 am |
RNS |
Recruitment of Second Patient for Clinical Trials |
| 13th Mar 2025 3:10 pm |
RNS |
Conversion of convertible loan notes |
| 11th Mar 2025 7:00 am |
RNS |
Institutional investment |
| 24th Feb 2025 7:00 am |
RNS |
First-in-Human Treatment with HG-CT-1 |
| 19th Feb 2025 4:50 pm |
RNS |
Issue of convertible loan notes |
| 31st Jan 2025 9:35 am |
RNS |
Total Voting Rights |
| 8th Jan 2025 7:00 am |
RNS |
Placing to raise £340,000 |
| 2nd Jan 2025 7:00 am |
RNS |
Change of Company Secretary and Registered Office |
| 31st Dec 2024 7:00 am |
RNS |
Total Voting Rights |
| 30th Dec 2024 7:00 am |
RNS |
Opening of First Clinical Site |
| 19th Dec 2024 7:00 am |
RNS |
Ultrafast CAR-T Manufacturing |
| 10th Dec 2024 4:10 pm |
RNS |
Admission of New Ordinary Shares and New ISIN |
| 9th Dec 2024 1:30 pm |
RNS |
Result of Extraordinary General Meeting |
| 9th Dec 2024 7:00 am |
RNS |
Site Initiation Visit Completed |
| 6th Dec 2024 7:00 am |
RNS |
CBR Macrophage Delivery Update |
| 29th Nov 2024 7:00 am |
RNS |
Total Voting Rights |
| 22nd Nov 2024 12:49 pm |
RNS |
Notice of Extraordinary General Meeting |
| 22nd Nov 2024 7:00 am |
RNS |
IRB Approval for Phase I Clinical Trial |
| 11th Nov 2024 7:00 am |
RNS |
Institutional Investment |
| 30th Oct 2024 7:00 am |
RNS |
Schedule for Phase I Clinical Trial Opening |
| 2nd Oct 2024 11:19 am |
RNS |
Strategic Investment from Prevail Partners, LLC |
| 27th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 9th Sep 2024 7:00 am |
RNS |
FLT3 Assay Ready for Phase I Trials at MD Anderson |
| 2nd Sep 2024 7:00 am |
RNS |
CDX Development Update |
| 28th Aug 2024 7:00 am |
RNS |
Presentation at CBD S&T Conference |
| 27th Jun 2024 4:39 pm |
RNS |
Result of Annual General Meeting |
| 17th Jun 2024 7:00 am |
RNS |
Operations Update |
| 3rd Jun 2024 7:00 am |
RNS |
Posting of Annual Report & Notice of AGM |
| 25th Apr 2024 7:00 am |
RNS |
Final Results |
| 28th Mar 2024 7:00 am |
RNS |
Total Voting Rights |
| 29th Feb 2024 7:00 am |
RNS |
Placing to Raise US$4.2 million |
